News/American Urological Association

Urology Virtual Assistant: Kidney Stone Program Management, Lithotripsy Scheduling, and Urology Oncology Surveillance

Aria·

Urology is a broad specialty, and the administrative demands of a full-service urology practice are correspondingly wide. Among the most underserved workflows in urology administration are kidney stone disease management — which involves metabolic evaluation, dietary counseling scheduling, and recurrence monitoring — shockwave lithotripsy coordination, and the long-cycle surveillance programs for bladder cancer, prostate cancer on active surveillance, and upper tract urothelial carcinoma. These are not simple scheduling tasks. They require protocol knowledge, tracking infrastructure, and consistent outreach — exactly what a trained urology virtual assistant is built to provide.

Kidney Stone Program: Metabolic Evaluation and Recurrence Monitoring

The American Urological Association's 2024 Medical Expulsive Therapy and Urolithiasis Guidelines recommend metabolic evaluation for all recurrent stone formers and for first-time formers with high-risk features. A complete metabolic workup involves two 24-hour urine collections (serum and urine chemistries, oxalate, urate, citrate, pH), dietary analysis, and a follow-up visit to interpret results and initiate dietary or pharmacologic intervention.

The challenge is operational: ordering the 24-hour urine kits, confirming the patient knows how to complete them, ensuring the specimens are returned to the correct lab, and scheduling the results-review visit before the patient drops out of follow-up. A urology VA manages every step: generating the lab order, arranging kit delivery or pickup, sending patients written instructions, confirming specimen return, and scheduling the results visit. For patients with recurrent stones, the VA tracks the annual monitoring cycle — repeat 24-hour urine, renal ultrasound or KUB X-ray to check for new stone burden — and generates outreach when surveillance is due.

According to the Endourology Society's 2023 Stone Disease Registry, practices with structured metabolic evaluation programs have a 42% lower 5-year stone recurrence rate compared to practices that treat stones episodically without follow-up programs. Administrative infrastructure is the rate-limiting factor.

Lithotripsy Scheduling: A Multi-Party Coordination Challenge

Shockwave lithotripsy (SWL) scheduling requires coordinating the lithotripter machine (which may be a mobile unit visiting on a fixed schedule), anesthesia or sedation availability, radiology confirmation of stone position and size, pre-procedure lab work, and anticoagulation management for patients on blood thinners. Missing any one element delays the procedure.

A urology VA manages the lithotripsy scheduling workflow: confirming machine availability on the next scheduled visit, booking anesthesia or nursing sedation support, ordering pre-procedure labs (CBC, BMP, coagulation studies), sending patients prep instructions (NPO status, anticoagulation hold instructions, transportation plan), and confirming insurance authorization covers the procedure at the chosen facility. For practices using a mobile lithotripter vendor (Dornier, Northgate), the VA manages communication with the vendor's scheduling coordinator to align patient slots with machine availability.

Urology Oncology Surveillance: Bladder and Prostate Cancer

Bladder cancer surveillance — particularly for non-muscle-invasive bladder cancer (NMIBC) — is one of the most labor-intensive surveillance programs in outpatient medicine. The AUA's surveillance protocol requires cystoscopy at 3 months, then 6 months, then annually for low-risk disease; and every 3 months for 2 years, then every 6 months for high-risk NMIBC. Each cystoscopy requires a scheduled procedure slot, urine cytology, and post-procedure documentation. Patients who miss a surveillance cystoscopy are at elevated risk for disease progression that might have been intercepted.

A urology VA maintains an active surveillance registry for NMIBC patients, tracks each patient's position on the surveillance ladder, generates scheduling outreach 30 to 45 days before the due date, orders the required urine cytology, coordinates the procedure room booking, and routes the pathology result to the provider for review and patient communication. When pathology reveals recurrence, the VA flags the case for urgent follow-up scheduling and notifies the treating urologist same-day.

For prostate cancer patients on active surveillance — managed per the AUA's AS criteria for very-low-risk and low-risk disease — the VA tracks the PSA testing schedule (every 6 to 12 months), surveillance biopsy intervals (every 12 to 24 months), and mpMRI scheduling. When a PSA velocity triggers a clinical decision point, the VA ensures the provider is notified and a follow-up visit is scheduled promptly.

Upper Tract Urothelial Carcinoma Follow-Up

UTUC surveillance after nephroureterectomy requires annual CT urography and cystoscopy for the first several years, with intervals extending for patients who remain disease-free. Managing the surveillance calendar for UTUC patients — particularly those co-managed with oncology — requires a structured tracking system. A VA maintains the surveillance schedule, coordinates the CT urography order and radiology scheduling, books the cystoscopy, and routes post-procedure results to the provider.

Integration With Urology EHR Platforms

Urology practices commonly use Epic, Athenahealth, or specialty platforms such as Modernizing Medicine for Urology or drchrono. A trained VA from Stealth Agents works within the practice's existing platform, managing scheduling queues, tracking open authorization requests, and documenting follow-up outreach without requiring access to the clinical chart beyond what the scheduling and authorization workflow demands.

Business Case for a Urology VA

Lost surveillance visits represent unbooked procedure revenue. A single missed cystoscopy is a lost procedure fee (typically $350 to $600). A bladder cancer patient who misses three surveillance visits and progresses to muscle-invasive disease represents an entirely preventable treatment escalation — with associated patient harm and liability exposure. A urology VA that closes 10 surveillance gaps per month at $450 average procedure revenue pays for itself in recovered bookings alone, before accounting for staff time savings.


Sources

  • American Urological Association. 2024 Urolithiasis and Medical Expulsive Therapy Guidelines. auanet.org
  • Endourology Society. 2023 Stone Disease Registry Annual Report. endourology.org
  • American Urological Association. Non-Muscle-Invasive Bladder Cancer Surveillance Guidelines. auanet.org
  • Medical Group Management Association. 2024 Urology Practice Benchmarks. mgma.com